Home/Filings/4/0001567619-22-021900
4//SEC Filing

Disbrow Joshua R. 4

Accession 0001567619-22-021900

CIK 0001385818other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 9:17 AM ET

Size

10.0 KB

Accession

0001567619-22-021900

Insider Transaction Report

Form 4
Period: 2022-12-19
Disbrow Joshua R.
Chief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-12-19$0.22/sh+112,371$25,0471,231,877 total
Footnotes (1)
  • [F1]The purchase price reported above is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.213 to $0.23, inclusive. The reporting person undertakes to provide to AYTU Biopharma, Inc., any security holder of AYTU Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Issuer

AYTU BIOPHARMA, INC

CIK 0001385818

Entity typeother

Related Parties

1
  • filerCIK 0001566240

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 9:17 AM ET
Size
10.0 KB